Development Insights is a strategic life sciences consulting firm specializing in fractional, project-based, and interim support across Regulatory Affairs, Clinical Operations, Quality, and CMC. We partner with biotech and pharmaceutical companies at every stage of development — from preclinical planning and IND submissions to commercial launch — offering senior-level expertise exactly when and where it’s needed. Our curated staff of consultants works as an extension of your internal team, bringing flexibility, speed, and deep experience to help navigate complex milestones with confidence. Whether you need a regulatory strategy lead, submission support, QA oversight, or clinical trial guidance, we deliver tailored solutions with fast execution and long-term impact. _________________________________________________________ Specialties: Regulatory Strategy • Translational Research • CMC Development • IND/NDA/BLA/IMPD/ CTA/QOS Submissions • eCTD Publishing • Clinical Trial Operations • Regulatory CMC • Quality Systems & GxP Compliance • Program Management • Interim Leadership
Looking for a particular Development Insights employee's phone or email?
The Development Insights annual revenue was $5.9 million in 2026.
Kimberly Sullivan is the President and CEO (Regulatory Affairs and Quality and Compliance Consultant) of Development Insights.
5 people are employed at Development Insights.
Development Insights is based in Chico, California.
The NAICS codes for Development Insights are [541, 54, 5417].
The SIC codes for Development Insights are [873, 87].